Hellenic Pulmonary Oncology Study Group

The Hellenic Pulmonary Oncology Study Group (HePONS) is a prominent non-profit scientific organization based in Greece, specializing in clinical research and the management of thoracic malignancies. Established in 1994, the group coordinates multicenter clinical trials to evaluate the efficacy of innovative treatments, including targeted therapies and immunotherapies, for lung cancer and mesothelioma. HePONS collaborates extensively with international research networks and the pharmaceutical industry to integrate global research standards into the Greek clinical landscape. The organization also provides educational resources and standardized treatment protocols to the medical community, aiming to improve patient outcomes in pulmonary oncology. Its research portfolio includes significant studies on optimized chemotherapy regimens and the application of novel biological agents.